Nebulizers and Vaporizers (Inhaler)

Subscribe to Selected New Research on Nebulizers and Vaporizers

1608 relevant articles (164 outcomes, 294 trials/studies) found for this Therapy

Description: Devices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments.

Also Known As:

Inhaler; Vaporizer; Nebulizer; Atomizer; Inhalers; Nebulizers; Inhalator; Vaporizers; Vaporizers and Nebulizers; Device, Inhalation; Devices, Inhalation; Inhalation Device; Atomizers; Inhalation Devices; Inhalators

Relationship Network

Therapy Context: Research Results

Equipment and Supplies

Nebulizers and Vaporizers: 1608

Metered Dose Inhalers: 662

Surgical Equipment: 28

Nebulizers and Vaporizers: 1608

Experts

1.	Poole, P: 5 articles (01/2007 - 01/2003)
2.	Lasserson, T J: 5 articles (01/2007 - 01/2003)
3.	Wright, J: 5 articles (12/2002 - 01/2001)
4.	Ankerst, Jaro: 4 articles (05/2008 - 01/2003)
5.	Cates, C J: 4 articles (01/2007 - 01/2004)
6.	Brocklebank, D: 4 articles (12/2002 - 01/2001)
7.	Price, David: 3 articles (04/2008 - 10/2004)
8.	Nannini, L: 3 articles (01/2007 - 01/2003)
9.	Bateman, Eric D: 3 articles (03/2006 - 01/2003)
10.	Buhl, R: 3 articles (04/2003 - 08/2001)

Related Diseases

1.	Asthma (Bronchial Asthma) 01/01/1997 - "This study helped to identify which selected inhaler characteristics are most important to patients with asthma" 10/01/2004 - "These highly effective anti-asthma medications are readily available, and so in the future improvement in asthma therapy will most Likely derive from improvements in inhaler technology" 10/01/2007 - "The correct use of inhaler devices is important for the efficacy of the treatment of childhood asthma" 03/01/2002 - "The results of this study showed that systematic nursing instruction of mothers of children with asthma significantly improved their knowledge of the medication, ability to use inhalation devices, and self-efficacy, as well as decreasing the number of episodes of respiratory disease of children over a two month period" 01/01/1996 - "The study revealed significant improvement in both children's and parent's knowledge and beliefs concerning asthma inhaler use technique which significantly improved and positive behavioral changes were reported" Order ALL the reference details at left...
2.	Chronic Obstructive Pulmonary Disease (COPD) 04/01/2005 - "Combining an inhaled corticosteroid and a long-acting beta-agonist in the same inhaler increases the efficacy of the latte drug in COPD patients, with a significantly larger improvement in FEV (1), a larger reduction in reported breathlessness, and a reduction in exacerbation numbers in those with severe disease where beta-agonists appear to be less effective" 01/01/2004 - "CONCLUSIONS: The use of written information about the use of inhalers for patients with COPD significantly improved utilization to a degree similar to that obtained with verbal explanations." 01/01/2005 - "Efficacy of nebulizer therapy with acetylcystein in outpatients with chronic obstructive lung disease]" 01/01/2004 - "OBJECTIVES: To determine whether the use of written information alone improved inhalation technique with pressurized canister inhalers in patients with chronic obstructive pulmonary disease (COPD)" 12/01/1999 - "Educated asthmatics showed improved steroid inhaler compliance compared with the uneducated patients, whereas this seemed unaffected by education in the COPD group." Order ALL the reference details at left...
3.	Respiratory Sounds (Crackle) 10/01/1999 - "Before study entry, the boy was experiencing more breakthrough wheezing episodes at night than the parents were used to, resulting in an increase in nighttime awakenings that required nebulizer therapy" 07/01/2006 - "RESULTS: Of the 500 respondents participating in the telephone interview, nearly one third (31.6%) named an inhaled corticosteroid or bronchodilator and inhaled corticosteroid combination as the inhaler used when wheezing, coughing, or short of breath" 09/01/2003 - "Metered-dose inhalers with home-made spacers versus nebulizers to treat moderate wheezing attacks in children]" 01/01/2003 - "CONCLUSION: Our data suggest that metered-dose inhalers with spacers may be as efficacious as nebulizers for the emergency department treatment of wheezing in children aged 2 years or younger." 01/01/2003 - "PATIENTS: From a convenience sample of wheezing children aged 2 to 24 months, 85 patients were enrolled in the nebulizer group and 83 in the spacer group" Order ALL the reference details at left...
4.	Airway Obstruction (Choking) 03/01/1988 - "While bronchodilator administration with the metered dose inhaler (MDI) and reservoir or spacer attachment is as effective as administration with the nebulizer in most settings, the former has not been widely accepted for treatment of acute airway obstruction in the emergency room" 12/01/1983 - "Delivery of META by a motorized mist nebulizer provides safe, effective bronchodilation and META is superior to the other agents tested in terms of onset of action, peak reversal of airway obstruction, and duration of effect." 01/01/2008 - "CONCLUSIONS: Dry powder inhalers are useful in the management of younger patients with normal lung function or mild airway obstruction" 02/01/1992 - "Taking into account previously published reports and the results of the present study, we conclude that differences in dose, administration technique, nebulizer system efficiency, and severity of airway obstruction can alter the amount of drug reaching the beta 2 receptors in the lungs and, thus, the clinical response." 03/01/2004 - "Day-to-day airway obstruction control, interpreted from patient recordings of symptom scores and inhaler use, was similar with both treatments" Order ALL the reference details at left...
5.	Cystic Fibrosis (Mucoviscidosis) 12/01/2007 - "Depending on the studies, contamination of the nebulizers may reach up to 55% of the devices in patients with cystic fibrosis" 12/01/2004 - "Nebulizer use and maintenance by cystic fibrosis patients: a survey study." 04/01/2001 - "STUDY OBJECTIVES: To develop a model that quantified the nebulizer output that was inhaled by subjects with cystic fibrosis (CF) in order to predict the amount of drug likely to enter the upper airway contained in particles small enough to be deposited in the lower respiratory tract of individual patients" 01/01/2001 - "The objective of this study was to evaluate relative efficiency in vitro of four reusable breath-enhanced nebulizers (Pari LC Star, Medic-Aid Ventstream, Devilbiss PermaNeb, Salter Ultramist), and to integrate the in vitro performance data of the nebulizers with the respiratory patterns of four cystic fibrosis (CF) patients to compare efficiency in vivo of each device for each individual patient" 10/01/2000 - "A total of 44 nebulizers were included: 37 from patients with P aeruginosa colonization with a count of 10(6) colony-forming units/mL or more and 7 with a count of between 10(5) colony-forming units/mL and 10(6) colony-forming units/mL. CONCLUSION: This study demonstrates that in the absence of cleaning, nebulizers of patients with cystic fibrosis who are infected with P aeruginosa are likely to be contaminated by a pathogenic flora." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Albuterol (Salbutamol)
2.	Budesonide (Pulmicort)
3.	formoterol (Oxis)
4.	fluticasone (Cutivate)
5.	salmeterol (Serevent)
6.	(3,4-dihydroxyphenylamino)-2-imidazoline (DPI)
7.	Ipratropium (Ipratropium Bromide)
8.	mometasone furoate (mometasone)
9.	Beclomethasone (Beclometasone)
10.	Adrenal Cortex Hormones (Corticosteroids)

Related Therapies and Procedures

1.	Metered Dose Inhalers (Metered Dose Inhaler)
2.	Nebulizers and Vaporizers (Inhaler)
3.	Flowmeters
4.	Aftercare (After-Treatment)
5.	Respiratory Therapy (Therapy, Respiratory)

Best Treatments:
Research Summary Report
on Asthma

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 2812 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>